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Amajority of Plasmodium falciparum strains invade erythrocytes through interactionswith sialic acid (SA)
on glycophorins. However, we recently reported that complement receptor 1 (CR1) is a SA-independent
invasion receptor of many laboratory strains of P. falciparum. To determine the role of CR1 in erythrocyte
invasion among P. falciparum field isolates, we tested eight isolates obtained from children in Kenya.
All the parasites examined were capable of invading in a SA-independent manner, and invasion of
neuraminidase-treated erythrocytes was nearly completely blocked by anti-CR1 and soluble CR1 (sCR1).
In addition, anti-CR1 and sCR1 partially inhibited invasion of intact erythrocytes in a majority of isolates
tested. Sequencing of the hypervariable region of P. falciparum AMA-1 showed considerable diversity
among all the isolates. These data demonstrate that CR1 mediates SA-independent erythrocyte invasion
in P. falciparum field isolates.
© 2011 Elsevier B.V. All rights reserved.
Plasmodium falciparum infections are the leading cause of
malaria-related morbidity and mortality in sub-Saharan Africa [1].
An integral part of the parasite’s life cycle in humans is the blood
stage, during which parasites repeatedly invade and multiply in
erythrocytes. This part of the life cycle is responsible for all the
morbidity and mortality. Therefore, vaccines targeting this stage
could potentially be effective in preventing disease. However, the
development of a blood stage vaccine is hampered by a lack of ade-
quate understanding of the molecular mechanisms through which
the parasite invades erythrocytes. Furthermore, it is important that
studies examiningerythrocyte invasionpathways includefieldpar-
asites since laboratory-adapted strains often differ significantly
from clinical isolates.
It is known that sialic acid (SA) residues on glycophorins are
an important receptor for the invasion of erythrocytes by P. falci-
parum [2,3]. However, a significant number of laboratory-adapted
and field strains of P. falciparum are capable of invading erythro-
cytes depleted of SA after treatment with neuraminidase [4–8],
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indicating the existence of one or more SA-independent inva-
sion pathways. In addition, studies of P. falciparum field isolates
from Kenya demonstrated that the vast majority (∼74%) of these
parasites relied on an unknown trypsin-sensitive receptor for SA-
independent invasion of erythrocytes [5,9].
Our recent investigations [10], now confirmed by others [11],
have identified complement receptor 1 (CR1, CD35) as the major
neuraminidase-resistant, trypsin-sensitive receptor used for SA-
independent invasion of erythrocytes by laboratory strains of P.
falciparum, including 3D7, 7G8, Dd2NM, and HB3. CR1 is a com-
plement regulatory protein that serves as co-factor in the factor
I-mediated cleavage of C3b to C3bi and also accelerates the decay
of C3 and C5 convertases. Our previous studies and those of oth-
ers have also shown that CR1 expression levels [12,13], as well as
genetic polymorphisms that influence CR1 expression [14–16], are
associated with susceptibility to severe malaria in children.
To extend our earlier findings with laboratory strains [10], we
investigated the role of CR1 in mediating erythrocyte invasion by
field isolates of P. falciparum by examining the ability of these iso-
lates to invade erythrocytes in the presence of CR1 inhibitors in
vitro. Parasite isolates used in this study were collected from chil-
dren diagnosed with acute malaria at hospitals in western Kenya,
under protocols approved by the Kenya National Ethical Commit-
tee and the Human Subjects Research Committee at the Walter
0166-6851/$ – see front matter © 2011 Elsevier B.V. All rights reserved.
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Table 1
CR1-dependent invasion of erythrocytes by P. falciparum clinical isolates.
Parasites Control Anti-CR1 IgY sCR1 -2M/Fetuin
Invasion of untreated erythrocytes expressed as % control (SD)
3D7 (n=3) 100.0 102.0 (3.5) 101.8 (5.2) 98.6 (4.7) 101.3 (3.6)
JASC8-19 (n=5) 100.0 82.6 (6.7)* 93.1 (4.6) 73.7 (7.1)* 100.2 (3.4)
SA005 (n=3) 100.0 90.2 (2.4) 93.5 (5.9) 69.4 (2.1)* 92.9 (3.8)
SA154 (n=3) 100.0 82.2 (7.0) 93.6 (1.9) 75.9 (8.3) 95.4 (3.4)
SA162 (n=4) 100.0 98.7 (3.8) 101.7 (3.6) 79.6 (2.9)* 99.5 (4.0)
SA222 (n=5) 100.0 84.7 (7.8)* 97.4 (4.5) 64.9 (3.9)* 100.9 (2.4)
SA250 (n=3) 100.0 82.8 (5.3) 92.9 (2.1) 72.9 (1.5)* 91.4 (1.4)
CM028 (n=5) 100.0 90.6 (8.9)* 99.9 (8.0) 70.5 (7.9)* 98.2 (5.3)
CM033 (n=3) 100.0 86.1 (4.9)* 99.0 (3.1) 78.9 (5.0)* 98.7 (5.4)
Invasion of neuraminidase-treated erythrocytes expressed as % untreated control (SD)
3D7 (n=3) 62.1 (5.5) 15.8 (2.6)* 62.1 (4.7) 8.4 (2.3)* 60.6 (4.8)
JASC8-19 (n=3) 45.2 (2.2) 10.8 (1.6)* 43.1 (2.8) 11.3 (1.8)* 44.0 (3.7)
SA005 (n=3) 42.8 (7.3) 11.4 (1.7)* 38.3 (2.6) 8.2 (1.8)* 38.4 (5.7)
SA154 (n=3) 39.7 (5.6) 14.9 (8.7)* 37.7 (5.5) 13.5 (7.7)* 40.0 (2.6)
SA162 (n=3) 49.1 (2.1) 8.5 (1.4)* 30.1 (0.8) 6.0 (0.6)* 31.2 (4.0)
SA222 (n=5) 36.8 (2.7) 13.2 (0.7)* 37.9 (4.7) 14.0 (2.4)* 34.4 (3.9)
SA250 (n=3) 36.0 (6.8) 15.8 (6.7)* 31.3 (5.7) 13.0 (5.8)* 33.4 (5.6)
CM028 (n=5) 43.6 (7.3) 9.4 (5.2)* 39.4 (6.5) 9.6 (5.9)* 40.4 (5.6)
CM033 (n=3) 37.5 (2.4) 10.8 (3.5)* 38.9 (4.0) 10.0 (3.7)* 36.5 (4.4)
P. falciparum isolates SA005, SA154, SA162, SA222, SA250, JASC8-19, CM028, and CM033were collected from childrenwithmalaria inwestern Kenya, while 3D7 is laboratory-
adapted strain. Parasites were cultivated on RPMI containing 0.2% NaHCO3, 0.1mM hypoxanthine and 10% normal serum (type O+), maintained at 37 ◦C and a gas mixture of
90%N2, 5%O2 and 5% CO2. Invasion assayswere set up in duplicates in 96-well plateswith 100L/well of culturemedia. Uninfected untreated erythrocytes or neuraminidase-
treated erythrocytes at 2% hematocrit were inoculated with purified schizonts to obtain 1–2% parasitemia. CR1-mediated invasion was inhibited with either 50g/mL of
sCR1 or 8g/mL of polyclonal chicken IgY raised against sCR1 (Gallus Immunotech Inc., Fergus, Canada). Fetuin and apha-2-macroglobulin (-2-M) were used as control
proteins, and chicken IgY as control antibody. After overnight incubation, erythrocytes were stained with Hoechst 33342 and invasion rates were calculated as the percentage
of ring-infected erythrocytes as determined by flow cytometry using a LSR-II system (Becton-Dickinson, San Diego, CA). “n” denotes the number of experiments. Data are
presented as means (SD) of three to five separate experiments for each parasite strain.
* Indicates that invasion inhibition by anti-CR1 or sCR1 was statistically significant compared to the effects of IgY or -2-M and fetuin, respectively (P<0.05 vs respective
control proteins, paired Student’s t-test).
Reed Army Institute of Research. The parasites were cultured for
1–2 weeks to adapt and synchronize before invasion assays were
performed. Schizonts were purified using Percoll gradient cen-
trifugation and used to inoculate uninfected erythrocytes at 1–2%.
Each experiment was set up in duplicate wells, and invasion rates
were averaged between the 2 wells. Three to five separate invasion
experiments were performed at 2-day intervals for each isolate.
Treatment of erythrocytes with the anti-CR1 polyclonal antibody
decreased invasion by 10–18% in all the parasites tested (Table 1).
The inhibitory effects elicited by anti-CR1 were statistically signif-
icant compared to the changes induced by control IgY antibodies
in four out of eight isolates tested (P<0.05, Table 1). In addition,
invasion of untreated erythrocytes by all parasite isolates tested
was inhibited by as much as 20–35% in the presence of sCR1. Com-
pared to the effects of control proteins-2-macroglobulin (-2-M)
or fetuin, inhibition of invasion by sCR1 was statistically significant
in seven out of eight parasite strains examined (P<0.05, Table 1). In
contrast, invasion of untreated erythrocytes by laboratory strains
such as 3D7 were not significantly affected by the presence of CR1
inhibitors (Table 1 and [10]), demonstrating the important contri-
bution that CR1 makes to invasion of the intact red cells by field
parasites.
All parasite isolates were capable of invading red cells in a
SA-independent manner, retaining 36–49% of their normal inva-
sion levels after erythrocytes were treated with neuraminidase
(Table 1). For comparison, 3D7 on the average retained 62%
of its invasion after treatment of erythrocytes with neu-
raminidase (Table 1). Anti-CR1 significantly inhibited invasion of
neuraminidase-treated erythrocytes in all parasites (P<0.01 com-
pared to IgY for all isolates; Table 1). These effects of anti-CR1
represented a 60–85% inhibition of SA-independent invasion in the
eight field parasites, suggesting that CR1 plays an important role
in SA-independent erythrocyte invasion. Furthermore, sCR1 sim-
ilarly decreased invasion of neuraminidase-treated erythrocytes
in the clinical parasites by 65–90% (P<0.01 compared to control
for all isolates). The relatively lower dependence of these para-
sites on CR1 for invasion of untreated erythrocytes compared to
neuraminidase-treated erythrocytes is consistent with the existing
notion that glycophorins are the primary or preferred receptors for
P. falciparum. Consistentwith our observations in laboratory strains
[10], these results indicate that CR1 is the previously unknown
SA-independent receptor used by a majority of wild P. falciparum
isolates.
To assess the extent of genetic diversity among the parasite iso-
lates that useCR1as an invasion receptor, a sequence analysis of the
highly polymorphic C1 cluster of P. falciparumAMA-1domain1was
performed. AMA-1plays a key role in erythrocyte invasion [17], and
amino acid substitutions within the C1 cluster have been shown to
confer antigenic escape from invasion inhibitory antibodies [18]. As
controls, two clones of JASC8-19 (JASC8-8 and JASC8-10), as well as
the laboratory strain 3D7 (GenBank accession number U65407.1)
were also analyzed. These analyses revealed that seven isolates,
JASC8-19, SA005, SA154, SA162, SA222, SA250, and CM028, were
genetically distinct with >25% differences in amino acid sequences
between some of them (Fig. 1). The eighth parasite, CM033, had a
sequence that was identical to SA154 at the same locus, suggest-
ing that these could be the same parasite. Furthermore, multiple
AMA1 sequences were detected in SA162 and CM028, indicating
that these isolates were mixtures of at least two different parasites.
Within the 30-amino acids spanning the C1 cluster, the sequences
of the seven distinct isolates differed from 3D7 by three to nine
aminoacid residues (Table2). Therefore, theuseofCR1asa receptor
for SA-independent invasion of erythrocytes was conserved across
a genetically diverse groupofparasites. Thesedata argue for abroad
reliance on CR1 as the major SA-independent receptor in widely
diverse field strains.
Our previous investigations demonstrated that CR1 is a major
receptor used by many laboratory strains of P. falciparum for SA-
independent invasion of erythrocytes [10]. Those findings marked
an important step towards the understanding of erythrocyte inva-
Author's personal copy
G.A. Awandare et al. / Molecular & Biochemical Parasitology 177 (2011) 57–60 59
Ta
b
le
2
A
m
in
o
ac
id
su
bs
ti
tu
ti
on
s
w
it
h
in
th
e
A
M
A
-1
C
1
cl
u
st
er
s
of
th
e
fi
el
d
is
ol
at
es
.
A
M
A
-1
C
1
cl
u
st
er
se
qu
en
ce
(a
m
in
o
ac
id
s
18
1–
21
0)
3D
7
F
A
F
P
P
T
E
P
L
M
S
P
M
T
L
D
E
M
R
H
F
Y
K
D
N
K
Y
V
K
N
SA
00
5
-
-
-
-
-
-
K
-
-
-
-
-
-
-
-
-
D
-
-
D
L
-
-
N
-
E
-
-
-
-
SA
15
4
-
-
-
-
-
-
N
-
-
I
-
-
-
-
-
N
G
-
K
D
-
-
-
-
-
E
D
-
-
-
SA
16
2-
A
-
-
-
-
-
-
N
-
-
-
-
-
-
-
-
N
G
-
-
-
-
-
-
N
-
E
-
-
-
-
SA
16
2-
B
-
-
-
-
-
-
N
-
-
-
-
-
-
-
-
N
H
-
-
D
-
-
-
-
-
E
-
-
-
-
SA
22
2
-
-
-
-
-
-
K
-
-
-
-
-
-
-
-
-
D
-
-
L
L
-
-
-
-
E
D
-
-
-
SA
25
0
-
-
-
-
-
-
N
-
P
-
-
-
-
-
-
N
G
-
-
D
L
-
-
N
-
E
D
-
-
-
JA
SC
8-
8
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
D
-
-
R
-
-
-
-
-
E
-
-
-
-
JA
SC
8-
10
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
D
-
-
R
-
-
-
-
-
E
-
-
-
-
JA
SC
8-
19
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
D
-
-
R
-
-
-
-
-
E
-
-
-
-
C
M
02
8-
A
-
-
-
-
-
-
K
-
-
I
-
-
-
-
-
-
-
-
-
D
L
-
-
N
-
E
-
-
-
-
C
M
02
8-
B
-
-
-
-
-
-
K
-
-
I
-
-
-
-
-
-
H
-
-
D
L
-
-
N
-
E
-
-
-
-
C
M
03
3
-
-
-
-
-
-
N
-
-
I
-
-
-
-
-
N
G
-
K
D
-
-
-
-
-
E
D
-
-
-
Th
e
p
ar
as
it
es
w
er
e
an
al
yz
ed
fo
r
th
e
C
1
cl
u
st
er
of
th
e
P.
fa
lc
ip
ar
um
ap
ic
al
m
em
br
an
e
p
ro
te
in
1
(A
M
A
-1
)
ge
n
e
[1
8]
.A
51
0-
bp
fr
ag
m
en
t
sp
an
n
in
g
th
e
h
yp
er
va
ri
ab
le
re
gi
on
of
A
M
A
-1
w
as
am
p
li
fi
ed
by
PC
R
u
si
n
g
fl
an
ki
n
g
p
ri
m
er
s
(f
or
w
ar
d
:
5′
-G
G
A
A
C
TC
A
A
TA
TA
G
A
C
TT
C
C
-3
′ a
n
d
re
ve
rs
e:
R
:
5′
-A
A
A
TT
C
TT
TC
TA
G
G
G
C
A
A
A
C
-3
′ )
[2
0]
an
d
th
e
p
ro
d
u
ct
w
as
se
qu
en
ce
d
on
an
A
B
IP
ri
sm
37
30
D
N
A
an
al
yz
er
.T
h
e
se
qu
en
ce
s
w
er
e
tr
u
n
ca
te
d
fr
om
am
in
o
ac
id
18
1–
21
0
th
at
re
p
re
se
n
t
th
e
C
1
p
ol
ym
or
p
h
ic
cl
u
st
er
of
th
e
A
M
A
1
ge
n
e
[1
8]
an
d
al
ig
n
ed
by
C
LU
ST
A
L
so
ft
w
ar
e.
P.
fa
lc
ip
ar
um
is
ol
at
es
SA
00
5,
SA
15
4,
SA
16
2,
SA
22
2,
SA
25
0,
JA
SC
8-
19
,C
M
02
8,
an
d
C
M
03
3
w
er
e
co
ll
ec
te
d
fr
om
ch
il
d
re
n
w
it
h
m
al
ar
ia
in
w
es
te
rn
K
en
ya
.J
A
SC
8-
8
an
d
JA
SC
8-
10
w
er
e
cl
on
ed
fr
om
JA
SC
8-
19
an
d
in
cl
u
d
ed
as
co
n
tr
ol
s,
as
w
el
la
s
th
e
co
m
m
on
la
bo
ra
to
ry
st
ra
in
3D
7.
A
M
A
-1
C
1
cl
u
st
er
se
qu
en
ce
d
at
a
ar
e
p
re
se
n
te
d
re
la
ti
ve
to
th
e
3D
7
se
qu
en
ce
.
Po
si
ti
on
s
at
w
h
ic
h
am
in
o
ac
id
s
ar
e
in
ag
re
em
en
t
w
it
h
3D
7
ar
e
in
d
ic
at
ed
by
“-
“.
M
u
lt
ip
le
A
M
A
-1
se
qu
en
ce
s
w
er
e
d
et
ec
te
d
in
SA
16
2
an
d
C
M
02
8
an
d
tw
o
p
os
si
bl
e
h
ap
lo
ty
p
es
w
er
e
p
re
se
n
te
d
fo
r
ea
ch
of
th
es
e
is
ol
at
es
.
Fig. 1. AMA-1C1cluster sequences showdiversity amongfield isolates.P. falciparum
isolates SA005, SA154, SA162, SA222, SA250, JASC8-19, CM028, and CM033 were
collected from children with malaria in western Kenya. JASC8-8 and JASC8-10 were
cloned from JASC8-19 and included as controls, as well as the common laboratory
strain 3D7. The genetic diversity among the isolates is illustrated by a phylogenetic
tree showing interrelationships according to the percentage differences in amino
acid sequences of the polymorphic AMA-1 C1 cluster. Multiple AMA-1 sequences
were detected in SA162 and CM028 and two possible haplotypes were presented
for each of these isolates.
sion by P. falciparum and brought us closer to achieving the goal
of developing an effective blood stage vaccine. In this study we
extended our studies to determine the relevance of our observa-
tions in field isolates which ultimately will be the target of any
potential malaria vaccine.
Unlike laboratory strains, where the contribution of CR1 to
invasion of untreated erythrocytes was small [10], nearly all
the clinical isolates tested here demonstrated a significant uti-
lization of CR1 for invasion of intact erythrocytes. The reasons
for this difference are unclear. However, it is possible that CR1
loss from red cells during in vitro culture may lead to selec-
tion of parasites with less reliance on CR1. In malaria-endemic
areas the use of CR1 as an invasion receptor may become more
significant due to immunological pressure from antibodies target-
ing the EBA proteins which mediate the SA-dependent pathway,
and field parasites could switch from complete or modest SA-
dependency to partial or more SA-independence. This hypothesis
is supported by evidence that children exposed to endemic P.
falciparum transmission acquire immunity to the SA-dependent
pathway before resistance to SA-independent invasion is devel-
oped [19]. This suggests that the role of CR1 in mediating
erythrocyte invasion in exposed individuals will increase as they
develop antibodies to the SA-dependent ligands EBA-175 and EBA-
140.
Taken together, our studies show that the use of CR1 as an inva-
sion receptor is common among Kenyan strains of P. falciparum.
Although a recent study showed that PfRh4 is a ligand for CR1 [11],
additional parasite ligands may exist. Therefore, characterization
of all the parasite ligand(s) that bind CR1 will be critical to increase
our understanding of the interaction of CR1 with the parasite.
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